Effect of calcitriol on the production of T-cell-derived cytokines in psoriasis

British Journal of Dermatology

Volumn 136, Issue 4, 1997, Pages 536-541

  Barna, M ^a,b   Bos, J D ^a   Kapsenberg, M L ^a   Snijdewint, F G M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PHORBOL ESTER; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL PROLIFERATION; DRUG MECHANISM; HUMAN; HUMAN TISSUE; KERATINOCYTE; PRIORITY JOURNAL; PSORIASIS; T LYMPHOCYTE;

EID: 0030939214     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb02137.x     Document Type: Article

References (30)

1. Norman AW, Roth J, Orei L. The vitamin D endocrine system: steroid metabolism, hormone receptor, and biological response (calcium binding proteins). Endocr Rev 1982; 3: 331-66.
2. Hausler MR, McCain TA. Basic and clinical concepts related to vitamin D metabolism and action. N Engl J Med 1977; 297: 974-83.
3. 3. Arch Dermatol 1987; 123: 1677-83a.
4. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 1986; 86: 709-14.
5. 3 sterols by alveolar macrophages from patients with sarcoidosis. J Exp Med 1985; 161: 755-65.
6. 3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol 1986; 98: 311-22.
7. 3 (calcitriol). J Clin Invest 1984; 74: 1451-55.
8. 3. J Clin Invest 1987; 79: 1659-64.
9. 3 and skin diseases. Arch Dermatol 1992; 284 (Suppl.): S30-6.
10. Holick MF. Active vitamin D compounds and analogues: a new therapeutic era for dermatology in the 21st century. Mayo Clin Proc 1993; 68: 925-7.
11. Kemény L, Michel G, Dobozy A, Ruzicka T. Cytokine system as potential target for antipsoriatic therapy. Exp Dermatol 1994; 3: 1-8.
12. Wong RL, Winslow CM, Cooper KD. The mechanisms of action of cyclosporin A in the treatment of psoriasis. Immunol Today 1993; 14: 69-74.
13. Uyemura K, Yamamura M, Fivenson DF et al. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993; 101: 701-5.
14. Schlaak JF, Buslau M, Jochum W et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 1994; 102: 145-9.
15. Vollmer S, Mensen A, Trommler P et al. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells. Eur J Immunol 1994; 24: 2377-82.
16. Barna M, Snijdewint FGM, van der Heijden FL et al. Characterization of lesional psoriatic skin T lymphocyte clones. Acta Derm Venereol (Stockh) 1994; Suppl. 186: 9-11.
17. 3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro. Immunol Lett 1993; 35: 177-82.
18. 3: preferential inhibition of Th1 functions (Review). J Nutrit 1995; 125: 1704S-8S.
19. + allergen-specitic T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991; 97: 389-94.
20. van der Pouw Kraan TM, van Kooten C, Rensink I, Aarden LA. Interleukln (IL)-4 production by human T cells: differential regulation of IL-4 vs. IL-2 production. Eur J Immunol 1992; 22: 1237-41.
21. van der Meide PH, Dubbeld M, Schellekens H. Monoclonal antibodies to human immune interferon and their use in a sensitive solid-phase ELISA. J Immunol Methods 1985; 79: 293-305.
22. Gillis S, Ferm E, Ou W, Smith KA. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol 1978; 120: 2027-32.
23. Fattah D, Quint DJ, Proudfoot A et al. In vitro and in vivo studies with purified recombinant human interleukin-5. Cytokine 1990; 2: 112-21.
24. Ruff MR, Gifford GE. Rabbit tumor necrosis factor: mechanisms of action. Infect Immun 1981; 31: 380-5.
25. 3 receptors on human leucocytes. Science 1983; 221: 1181-3.
26. Matsumoto K, Azuma Y, Kiyoki M et al. Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytes. Biochim Biophys Acta 1991; 1092: 311-18.
27. Baadsgaard O. Potential mechanisms of action of vitamin D and analogues in psoriasis. Acta Derm Venereol (Stockh) 1994; Suppl. 186: 43.
28. Danielsson C, Schräder M, Carlberg C. A display of vitamin D responsive genes. In: Abstract Book of Vitamin D: Actions and Applications in Dermatology. ESDR Clinically Oriented Symposium. Aarhus, 1995; 39.
29. 3. J Clin Endocrinol Metab 1989; 69: 127-33.
30. 3 analogue MC903 on secretion of interleukin-1alpha (IL-1α) an IL-8 by normal human keratinocytes and a human squamous cell carcinoma cell line (HSC-1). J Dermatol Sci 1994; 7: 24-31.